Ursa Medicines

Company

Ursa Medicines develops one asset, in phase 1 (VELA-101 in hyperlipidemia). Mostly small molecule acting on lipid and ceramide metabolism.

1
Asset
Furthest stage
Phase 1
1
Trial
2
Signals

Pipeline

1

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials1
  • Signals2
  • Similar companies6

Intelligence